TheEdgeResearch
Home / Stocks / ROMJF

Rubicon Organics Inc. (ROMJF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.33 ▼ -12.45%
Market Cap
$22.2M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.38
52-Wk Range
0.274-0.542
CEO
Margaret Ruth Brodie
Country
CA
Currency
USD

Rubicon Organics Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.33, down 12.45% on the session, giving a market capitalisation of $22.2M. On trailing twelve-month figures it carries a trailing P/E of -26.49, a net margin of -2.3%. Its beta of 0.38 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-26.49
Price / Sales
0.54
Price / Book
0.83
EV / EBITDA
-25.25
Gross margin
21.0%
Operating margin
-8.9%
Net margin
-2.3%
Return on equity
Debt / equity
0.32
Current ratio
2.54
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
208
IPO date
2018-10-24
Headquarters
Vancouver, BC, CA
About Rubicon Organics Inc.

Founded in 2015, Rubicon Organics Inc. is headquartered in Vancouver, Canada, where it focuses on the cultivation, processing, and distribution of organic cannabis. The company supplies its organic cannabis products to both the adult-use and therapeutic markets across Canada, offering them under its own exclusive brands as well as other licensed labels.

Comparable companies

Rubicon Organics Inc. is most often compared with the following Healthcare names:

AVCNFCAAOFCNTMFCWBHFEOFBFGBLPHSTIISCNFMEDIFVYYRF
More research on ROMJF
ROMJF technical analysis ROMJF TheEdge Score Compare against peers
Open full interactive analysis & DCF →